CoChat
Cited by 200

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Risk Models to Predict Chronic Kidney Disease and Its Progression: A Systematic Review

Open access
Echouffo-Tcheugui, Justin B., Kengne, Andre P. · 2012 · PLoS Medicine

Abstract

BACKGROUND: Chronic kidney disease (CKD) is common, and associated with increased risk of cardiovascular disease and end-stage renal disease, which are potentially preventable through early identification and treatment of individuals at risk. Although risk factors for occurrence and progression of CKD have been identified, their utility for CKD risk stratification through prediction models remains unclear. We critically assessed risk models to predict CKD and its progression, and evaluated their suitability for clinical use. METHODS AND FINDINGS: We systematically searched MEDLINE and Embase (1 January 1980 to 20 June 2012). Dual review was conducted to identify studies that reported on the development, validation, or impact assessment of a model constructed to predict the occurrence/presence of CKD or progression to advanced stages. Data were extracted on study characteristics, risk predictors, discrimination, calibration, and reclassification performance of models, as well as validation and impact analyses. We included 26 publications reporting on 30 CKD occurrence prediction risk scores and 17 CKD progression prediction risk scores. The vast majority of CKD risk models had acceptable-to-good discriminatory performance (area under the receiver operating characteristic curve>0.70) in the derivation sample. Calibration was less commonly assessed, but overall was found to be acceptable. Only eight CKD occurrence and five CKD progression risk models have been externally validated, displaying modest-to-acceptable discrimination. Whether novel biomarkers of CKD (circulatory or genetic) can improve prediction largely remains unclear, and impact studies of CKD prediction models have not yet been conducted. Limitations of risk models include the lack of ethnic diversity in derivation samples, and the scarcity of validation studies. The review is limited by the lack of an agreed-on system for rating prediction models, and the difficulty of assessing publication bias. CONCLUSIONS: The development and clinical application of renal risk scores is in its infancy; however, the discriminatory performance of existing tools is acceptable. The effect of using these models in practice is still to be explored.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1001344

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 37

  1. QL Zhang, 2008, Prevalence of chronic kidney disease in population-based studies: systematic review, BMC Public Health, 8, 117, 10.1186/1471-2458-8-117 · DOI · Paper page
  2. S Khan, 2008, Economic burden of chronic kidney disease, J Eval Clin Pract, 14, 422, 10.1111/j.1365-2753.2007.00883.x · DOI
  3. HA Fink, 2012, Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline, Ann Intern Med, 156, 570, 10.7326/0003-4819-156-8-201204170-00008 · DOI
  4. K Uhlig, 2012, Developing guidelines for chronic kidney disease: we should include all of the outcomes, Ann Intern Med, 156, 599, 10.7326/0003-4819-156-8-201204170-00012 · DOI
  5. A Whaley-Connell, 2012, Awareness of kidney disease and relationship to end-stage renal disease and mortality, Am J Med, 125, 661, 10.1016/j.amjmed.2011.11.026 · DOI
  6. A Akbari, 2012, Change in appropriate referrals to nephrologists after the introduction of automatic reporting of the estimated glomerular filtration rate, CMAJ, 184, E269, 10.1503/cmaj.110678 · DOI
  7. BM Reilly, 2006, Translating clinical research into clinical practice: impact of using prediction rules to make decisions, Ann Intern Med, 144, 201, 10.7326/0003-4819-144-3-200602070-00009 · DOI · Paper page
  8. 2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1
  9. U Heemann, 2011, Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement, Nephrol Dial Transplant, 26, 2099, 10.1093/ndt/gfr169 · DOI
  10. E Imai, 2011, Japan Association of Chronic Kidney Disease Initiatives (J-CKDI), Japan Med Assoc J, 54, 403
  11. H Bang, 2007, SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease, Arch Intern Med, 167, 374, 10.1001/archinte.167.4.374 · DOI · Paper page
  12. I Blech, 2011, Predicting diabetic nephropathy using a multifactorial genetic model, PLoS ONE, 6, e18743, 10.1371/journal.pone.0018743 · DOI
  13. A Thakkinstian, 2011, A simplified clinical prediction score of chronic kidney disease: a cross-sectional-survey study, BMC Nephrol, 12, 45, 10.1186/1471-2369-12-45 · DOI
  14. KS Kwon, 2012, A simple prediction score for kidney disease in the Korean population, Nephrology (Carlton), 17, 278, 10.1111/j.1440-1797.2011.01552.x · DOI
  15. KL Chien, 2010, A prediction model for the risk of incident chronic kidney disease, Am J Med, 123, 836, 10.1016/j.amjmed.2010.05.010 · DOI
  16. M Ando, 2011, A simple model for predicting incidence of chronic kidney disease in HIV-infected patients, Clin Exp Nephrol, 15, 242, 10.1007/s10157-010-0393-x · DOI
  17. MJ Jardine, 2012, Prediction of kidney-related outcomes in patients with type 2 diabetes, Am J Kidney Dis
  18. CS Fox, 2010, A multi-marker approach to predict incident CKD and microalbuminuria, J Am Soc Nephrol, 21, 2143, 10.1681/ASN.2010010085 · DOI
  19. CM O'Seaghdha, 2012, Performance of a genetic risk score for CKD stage 3 in the general population, Am J Kidney Dis, 59, 19, 10.1053/j.ajkd.2011.08.030 · DOI
  20. CM O'Seaghdha, 2012, A risk score for chronic kidney disease in the general population, Am J Med, 125, 270, 10.1016/j.amjmed.2011.09.009 · DOI
  21. N Tangri, 2011, A predictive model for progression of chronic kidney disease to kidney failure, JAMA, 305, 1553, 10.1001/jama.2011.451 · DOI · Paper page
  22. J Hippisley-Cox, 2010, Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores, BMC Fam Pract, 11, 49, 10.1186/1471-2296-11-49 · DOI · Paper page
  23. AV Kshirsagar, 2008, A simple algorithm to predict incident kidney disease, Arch Intern Med, 168, 2466, 10.1001/archinte.168.22.2466 · DOI
  24. G Collins, 2012, Predicting the risk of chronic kidney disease in the UK: an evaluation of QKidney(R) scores using a primary care database, Br J Gen Pract, 62, 243, 10.3399/bjgp12X636065 · DOI
  25. H Bang, 2008, Validation and comparison of a novel screening guideline for kidney disease: KEEPing SCORED, Arch Intern Med, 168, 432, 10.1001/archinternmed.2007.122 · doi:10.1001/archinternmed.2007.122
  26. H Bang, 2009, Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience, Nephrol Dial Transplant, 24, 2452, 10.1093/ndt/gfp124 · doi:10.1093/ndt/gfp124
  27. WF Keane, 2006, Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study, Clin J Am Soc Nephrol, 1, 761, 10.2215/CJN.01381005 · DOI · Paper page
  28. AS Desai, 2011, Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD, Am J Kidney Dis, 58, 717, 10.1053/j.ajkd.2011.05.020 · DOI
  29. M Goto, 2009, Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm, Nephrol Dial Transplant, 24, 1242, 10.1093/ndt/gfn610 · DOI
  30. M Goto, 2009, A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study, Nephrol Dial Transplant, 24, 3068, 10.1093/ndt/gfp273 · DOI · Paper page
  31. K Wakai, 2006, A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study, Nephrol Dial Transplant, 21, 2800, 10.1093/ndt/gfl342 · DOI · Paper page
  32. ES Johnson, 2008, Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study, Am J Kidney Dis, 52, 653, 10.1053/j.ajkd.2008.04.026 · DOI
  33. MJ Landray, 2010, Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study, Am J Kidney Dis, 56, 1082, 10.1053/j.ajkd.2010.07.016 · DOI · Paper page
  34. S van Dieren, 2012, Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review, Heart, 98, 360, 10.1136/heartjnl-2011-300734 · DOI · Paper page
  35. SI Hallan, 2009, Combining GFR and albuminuria to classify CKD improves prediction of ESRD, J Am Soc Nephrol, 20, 1069, 10.1681/ASN.2008070730 · DOI · Paper page
  36. N Halbesma, 2011, Development and validation of a general population renal risk score, Clin J Am Soc Nephrol, 6, 1731, 10.2215/CJN.08590910 · DOI
  37. M Alssema, 2012, One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease, Diabetes Care, 35, 741, 10.2337/dc11-1417 · DOI

Cited by

See all 200

Metadata

Authors
Echouffo-Tcheugui, J. B., & Kengne, A. P.
Venue
PLoS Medicine
Published
2012-11-20
Volume
9
Issue
11
Pages
e1001344
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W1990540788
Cited by
200
References
7
FWCI
1.36
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.